Reuters logo
Reckitt Benckiser beats earnings forecasts
February 13, 2013 / 7:15 AM / 5 years ago

Reckitt Benckiser beats earnings forecasts

LONDON, Feb 13 (Reuters) - Britain’s Reckitt Benckiser beat full-year earning expectations as the maker of Strepsils and Mucinex benefited from an unusually heavy U.S. cold and flu season in the final quarter.

Full-year adjusted earnings per share was 264.4 pence, compared to Thomson Reuters I/B/E/S estimates of 246.8 pence and a company-supplied forecast of 249 pence.

An early and unusually intense flu season in North America has pushed up business for hospitals, pharmacies and the makers of tissues and cold remedies.

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below